Next Generation Sequencing (NGS): The Next Big Thing

“NGS has subdued the genetic data throughput costs substantially”, says RNCOS.

 

Noida, UP -- (SBWIRE) -- 12/11/2014 -- With its unprecedented throughput, scalability, and speed, NGS enables researchers to study biological systems at a level never before possible. Innovative NGS sample preparation and data analysis options enable a broad range of applications. As new innovations and disease diagnosis techniques arrive in the market, NGS platforms can be built accordingly. NGS manufacturers continue to heavily invest in clinical applications for NGS. It is expected that over the next few years, the clinical applications will focus primarily on non-invasive prenatal testing (NIPT) and oncology with other applications in infectious diseases, HLA typing, and idiopathic diseases.

RNCOS, in its latest research report titled "Genetic Testing Market Outlook 2018", highlighted that the global NGS market is poised to surpass US$ 3 Billion mark by 2018. The US and Europe exhibit the highest market penetration for next generation sequencing. In recent times, the global market has seen an introduction of new low priced technologies such as PGM, Ion Proton and MiSeq. The emerging platforms are low-cost (e.g., GridION), most likely marking the end of growth of expensive instruments. The major players in the NGS segment include Illumina, Life Technologies, and Roche.

Holistically, the research report thoroughly discusses the global genetic testing industry in terms of the overall market size. Moreover, the disease wise and region wise analysis is also discussed in detail. Apart from the statistical data analysis highlighted above, qualitative data including the emerging sector for genetic testing industry and the government regulations are also elicited exhaustively. The competition across the global genetic testing sector is intensifying with the days passing by. With new service providers entering the market and accelerated R&D activities, the application of genetic testing and the industry as a whole is bound to witness a swift growth in the years to come.

For FREE SAMPLE of this report visit:
http://www.rncos.com/Report/IM720.htm

Check Related REPORTS on:
http://www.rncos.com/Healthcare_Industry.htm

About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.